Ramipril & Amlodipine Tablets (5mg/5mg, 5mg/10mg, 10mg/5mg, 10mg/10mg)

Healthy Inc is a specialized global supplier and exporter of advanced cardiovascular, anti-hypertensive, and critical-care therapeutics. We provide ultra-high-purity, kinetically stabilized Ramipril & Amlodipine (as Besilate) Hard Capsules / Film-Coated Tablets, manufactured in WHO–GMP certified, high-precision, humidity-controlled oral solid dosage facilities. This “ACE Inhibitor & Calcium Channel Blocker Synergy” is a highly lucrative, massive-volume export to cardiology centers, internal medicine clinics, retail pharmacy networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, first-line intervention for severe, uncontrolled Essential Hypertension and cardiovascular risk reduction.

Product Overview

This highly advanced Fixed-Dose Combination masterfully synchronizes a highly tissue-penetrating ACE inhibitor with a profound, long-acting calcium channel blocker, delivering unparalleled 24-hour blood pressure control while actively neutralizing each other’s side effects.

The “Hemodynamic Synergy & Edema Shield” Specialist:

• Mechanism 1 (The RAAS Blocker – Ramipril): Ramipril is a powerful Angiotensin-Converting Enzyme (ACE) inhibitor. It aggressively blocks the production of Angiotensin II, a potent chemical that forcefully constricts blood vessels. By shutting this down, Ramipril relaxes the blood vessels and significantly reduces the workload on the heart, actively preventing maladaptive cardiac remodeling and protecting the kidneys (renoprotective) in diabetic patients.
• Mechanism 2 (The Arterial Vasodilator – Amlodipine): Amlodipine is a gold-standard dihydropyridine calcium channel blocker. It prevents calcium ions from entering the smooth muscle cells lining the arteries. Without calcium, the arterial muscles physically cannot contract, leading to profound, sustained arterial dilation and a massive drop in peripheral vascular resistance.
• The “Edema Shield” Advantage (CRITICAL CLINICAL BENEFIT): When used alone, Amlodipine dilates the arteries but not the veins. This creates a pressure mismatch that forces fluid out of the capillaries, causing severe, painful ankle swelling (peripheral edema). Ramipril solves this perfectly. By actively dilating the venous side of the capillary bed, Ramipril equalizes the pressure, allowing the fluid to drain normally and drastically reducing the incidence of Amlodipine-induced edema.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Cardiology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Alkaline Micro-Environment Engineering: Formulating Ramipril alongside Amlodipine is exceptionally difficult due to Ramipril’s susceptibility to hydrolytic and mechanical stress during compression. Our facilities utilize advanced dry-blending techniques and incorporate specialized alkaline stabilizers to create a micro-pH environment within the tablet matrix. This completely prevents the Ramipril from cyclizing into toxic/inactive degradants over the product’s multi-year shelf life.

Therapeutic Indications (Human Use)

Indicated for the comprehensive, multi-pathway management of severe cardiovascular disease:

• Essential Hypertension: Substitution therapy for patients whose blood pressure is adequately controlled with Ramipril and Amlodipine given concurrently at the same dose levels, or as initial therapy for severe hypertension requiring dual-pathway intervention.
• Cardiovascular Risk Reduction: Prophylaxis of myocardial infarction, stroke, and cardiovascular death in high-risk patients.

Dosage & Administration

Recommended Dosage (Strictly as per Cardiologist Guidelines):

• Standard Adult Dosing: One tablet or capsule taken orally once daily.
• Administration: Must be taken at the same time every day. It can be taken with or without food. Tablets/Capsules must be swallowed whole with fluid.
• Hepatic/Renal Impairment: Dose titration must be performed meticulously, as both drugs require functional clearance pathways. Contraindicated in severe hepatic impairment.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Fetal Toxicity): When pregnancy is detected, discontinue this medication immediately. Drugs that act directly on the renin-angiotensin system (Ramipril) can cause profound injury, massive malformations, and death to the developing fetus.
• Angioedema Risk: ACE inhibitors can cause sudden, life-threatening swelling of the face, lips, tongue, and airway (angioedema) at any time during therapy. Patients must seek immediate emergency care if this occurs.
• The ACE Inhibitor Dry Cough: Ramipril prevents the breakdown of bradykinin in the lungs. This can cause a chronic, persistent, non-productive dry cough in up to 10% of patients. If the cough becomes intolerable, the patient must be switched to an ARB (like Valsartan or Telmisartan).
• Severe Hypotension & Hyperkalemia: This combination exerts massive blood-pressure-lowering effects. Severe hypotension may occur upon initiation. Serum potassium must be monitored regularly, as Ramipril forces the body to retain potassium.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Cardiovascular Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for cardiology wards in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.